Kforce Clinical Research, a division of Kforce, Inc. (NASDAQ: KFRC), has won Merck & Co. Inc.'s "Outstanding Operational Award in Clinical Development" as part of Merck's 2007 Supplier Recognition Awards.
Kforce Clinical Research Wins Operational Award from Merck
TAMPA, Fla. – (Sept. 10, 2008) – Kforce Clinical Research, a division of Kforce, Inc. (NASDAQ: KFRC), has won Merck & Co. Inc.’s “Outstanding Operational Award in Clinical Development” as part of Merck's 2007 Supplier Recognition Awards. Kforce Clinical Research was one of 13 suppliers to be recognized at the pharmaceutical company’s Annual Supplier Recognition Forum at their headquarters in Whitehouse Station, N.J., on June 12.
Four years ago Merck established its “Plan to Win” program. In June of this year, Merck invited 75 suppliers to the Recognition Forum where key executives discussed Merck’s critical initiatives and these suppliers’ role in helping Merck achieve its Plan to Win. Ultimately, 13 suppliers were identified for their accomplishments in this initiative.
Kforce Clinical Research provides customized and flexible functional outsourcing solutions to the biopharmaceutical industry. It specializes in clinical monitoring, site and study management, drug safety, clinical data management, data entry, clinical programming and biostatistics. Where as other outsourcing providers either augment a company’s drug trial with people or handle all aspects of the trial, Kforce’s functional outsourcing model offers a flexible, tailored approach developed to mirror each company’s business model and address specific requirements of the drug trial itself.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.